Company Profile
The Genelux Difference
Genelux is a Phase 3 biopharmaceutical company developing powerful therapeutics for patients suffering from difficult-to-treat cancers. The Company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor’s sophisticated defense mechanisms.
American Stock Transfer and Trust (AST)
59 Maiden Lane
New York, NY 10038
By Phone:
(800) 937-5449 toll free
(212) 936-5100 international